$ Value
$0
Shares
4,861
Price
$0
Filed
Aug 15
Insider
Name
Dreyer Scott
Title
EVP & Chief Commercial Officer
CIK
0001746251
Roles
Transaction Details
Transaction Date
2025-08-13
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,389
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024. | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option is fully vested and exercisable.
Filing Info
Dreyer Scott's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | COLL | A | $0 |
| 2026-02-10 | COLL | A | $0 |
| 2026-02-10 | COLL | F | $466K |
| 2026-02-10 | COLL | F | $1.0M |
| 2025-12-08 | COLL | M | $280K |
| 2025-12-08 | COLL | ▼ | $533K |
| 2025-12-08 | COLL | ▼ | $315K |
| 2025-12-08 | COLL | M | $0 |
| 2025-08-18 | COLL | M | $350K |
| 2025-08-18 | COLL | ▼ | $626K |
Other Insiders at COLL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Karnani Vikram
President and CEO
|
— | — | 2026-02-10 |
|
Dreyer Scott
EVP & Chief Commercial Officer
|
— | — | 2026-02-10 |
|
Smith Thomas B
EVP and Chief Medical Officer
|
— | — | 2026-02-10 |
|
Tupper Colleen
EVP & Chief Financial Officer
|
— | — | 2026-02-10 |
|
Dieter David
EVP & General Counsel
|
— | — | 2026-03-17 |